|
|
|
|
| LEADER |
01290nam a2200325 u 4500 |
| 001 |
10053921 |
| 003 |
upatras |
| 005 |
20220120140823.0 |
| 008 |
050523s2004 lu eng |
| 020 |
|
|
|a 9291681687
|
| 040 |
|
|
|a GR-PaULI
|c GR-PaULI
|
| 041 |
0 |
|
|a eng
|
| 082 |
0 |
4 |
|a 615.1
|
| 245 |
1 |
0 |
|a Hepatitis C and injecting drug use
|b impact, costs and policy options
|c editors Johannes Jager, Wien Limburg, Mirjam Kretzschmar...[et al.]
|
| 260 |
|
|
|a Luxembourg
|b Office for Official Publications of the European Communities
|c 2004
|
| 300 |
|
|
|a 389 p.
|b tab., fig.
|c 24 cm.
|
| 490 |
0 |
|
|a EMCDDA Monographs series
|v 7
|
| 504 |
|
|
|a Includes abbreviations
|
| 650 |
|
4 |
|a Ναρκωτικά
|9 7431
|
| 650 |
|
4 |
|a Ήπαρ
|x Ασθένειες
|9 32311
|
| 650 |
|
4 |
|a Ηπατίτιδα
|9 43938
|
| 700 |
1 |
|
|a Jager, Johannes
|4 edt
|9 46362
|
| 700 |
1 |
|
|a Limburg, Wien
|4 edt
|9 46363
|
| 700 |
1 |
|
|a Kretzschmar, Mirjam
|4 edt
|9 46364
|
| 760 |
0 |
|
|a EMCDDA Monographs series
|g 7
|
| 852 |
|
|
|a GR-PaULI
|b ΠΑΤΡΑ
|b ΒΚΠ
|b ΚΕΤ
|h 615.1 JAG
|m 078601
|p 025000115283
|t 1
|
| 942 |
|
|
|2 ddc
|
| 952 |
|
|
|0 0
|1 0
|4 0
|6 615_100000000000000_JAG
|7 0
|9 48181
|a LISP
|b LISP
|c EDC
|d 2016-04-24
|i 078601
|l 0
|o 615.1 JAG
|p 025000115283
|r 2016-04-24 00:00:00
|t 1
|w 2016-04-24
|y BK15
|
| 998 |
|
|
|c ΗΛΙΟΠΟΥΛΟΥ
|d 2005-05
|
| 999 |
|
|
|c 30546
|d 30546
|
